Skip to main content

Market Overview

Clover Health Short Sellers Lost $502M On Tuesday

Share:
Clover Health Short Sellers Lost $502M On Tuesday

Love it or hate it, Medicare insurance technology company Clover Health Investments Corp (NASDAQ: CLOV) is the latest Reddit short squeeze stock ripping higher this week.

The stock gained 86% on heavy volume Tuesday as a massive short squeeze continued, and S3 Partners analyst Ihor Dusaniwsky said Clover short sellers are racking up major losses.

What Happened? Since completing its highly anticipated SPAC merger back in January, Clover was a major disappointment for investors from day one.

In fact, the stock spent much of the last three months trading below $10 per share. In May, Clover reported just 18% revenue growth in the first quarter and a net loss of $48.4 million.

Despite these underwhelming numbers, Clover shares have skyrocketed more than 127% in the last month, driven in large part by a spectacular short squeeze.

Related Link: Why Naked Short Selling Is Not As Prevalent As You Think

On Tuesday, Dusaniwsky said Clover still has $585 million in short interest. Dusaniwsky estimates Clover’s short percent of float at 43.5%, making it one of the most heavily shorted stocks in the market. Year-to-date in 2021, Dusaniwsky said Clover short sellers have already endured a 210% loss on their positions.

In addition to daily hammering in the open market, Dusaniwsky said Clover short sellers are paying a 2% stock borrow fee.

What’s Next? Dusaniwsky said Clover short sellers have been willing to weather the storm so far this week. Despite a $502-million loss on Tuesday alone, Clover’s short interest has increased by 4.5 million shares in the last week.

“Short sellers look to be shorting into a rising market and an overheated stock, looking for a pullback off of these elevated levels. But shorting into a rising market produces mark-to-market losses, and today’s price spike has resulted in big red numbers for short sellers,” Dusaniwsky said.

Benzinga’s Take: Traders should be extremely careful trying to time the squeeze and any potential pullback. Short squeezes are notoriously volatile and unpredictable, even to some of the most experienced stock traders.

Latest Ratings for CLOV

DateFirmActionFromTo
Feb 2022SVB LeerinkMaintainsMarket Perform
Feb 2022Canaccord GenuityInitiates Coverage OnBuy
Feb 2022Cowen & Co.UpgradesUnderperformMarket Perform

View More Analyst Ratings for CLOV

View the Latest Analyst Ratings

 

Related Articles (CLOV)

View Comments and Join the Discussion!

Posted-In: Ihor Dusaniwsky S3 PartnersAnalyst Color Top Stories Analyst Ratings Trading Ideas Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com